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Abstract
Objectives: To estimate HIV prevalence and characterize risk factors among young adults in Asembo, rural western Kenya.
Design: Community-based cross-sectional survey.
Methods: From a demographic surveillance system, we selected a random sample of residents aged 13-34 years, who were
contacted at home and invited to a nearby mobile study site. Consent procedures for non-emancipated minors required
assent and parental consent. From October 2003 - April 2004, consenting participants were interviewed on risk behavior
and tested for HIV and HSV-2. HIV voluntary counseling and testing was offered.
Results: Of 2606 eligible residents, 1822 (70%) enrolled. Primary reasons for refusal included not wanting blood taken, not
wanting to learn HIV status, and partner/parental objection. Females comprised 53% of 1762 participants providing blood.
Adjusted HIV prevalence was 15.4% overall: 20.5% among females and 10.2% among males. HIV prevalence was highest in
women aged 25-29 years (36.5%) and men aged 30-34 years (41.1%). HSV-2 prevalence was 40.0% overall: 53% among
females, 25.8% among males. In multivariate models stratified by gender and marital status, HIV infection was strongly
associated with age, higher number of sex partners, widowhood, and HSV-2 seropositivity.
Conclusions: Asembo has extremely high HIV and HSV-2 prevalence, and probable high incidence, among young adults.
Further research on circumstances around HIV acquisition in young women and novel prevention strategies (vaccines,
microbicides, pre-exposure prophylaxis, HSV-2 prevention, etc.) are urgently needed.
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Introduction
African youth are disproportionately affected by the global HIV
pandemic. Of 10 million HIV-infected persons aged 15-24 years,
62% live in sub-Saharan Africa; the majority are female. [1] The
2007 Kenya Aids Indicator Survey (KAIS) demonstrated a
national HIV prevalence of 7.4% among Kenyans aged 15-49
years; 8.8% in females and 5.5% in males. [2] Among adolescents
aged 15-19 years, HIV prevalence was 3.5% in females and 1.0%
in males, increasing to 7.4% and 1.9% respectively among those
aged 20-24 years. [2] Nyanza Province in western Kenya
continues with Kenya’s highest HIV prevalence of 15.0%;
17.6% in women and 11.4% in men. [2] The KAIS HIV
prevalence data varied slightly, a non-statistically significant
difference, from the 2003 Kenya Demographic Health Survey
(KDHS). [3]
In Nyanza Province, the Kenya Medical Research Institute
(KEMRI) and the U.S. Centers for Disease Control and
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Prevention (CDC) have conducted infectious disease research
since 1988 in Asembo, a rural community. [4] An ongoing
demographic surveillance system (DSS) in this area reports a life
expectancy at birth of 38 years and high adult mortality rates likely
attributable to AIDS. [5] In 2002 the Institute of Tropical
Medicine in Antwerp, Belgium (ITM), with KEMRI/CDC,
initiated a multi-component adolescent prevention intervention
in Asembo. This intervention was in response to a needs
assessment, conducted by ITM and KEMRI/CDC among
Nyanza youth, and to findings from a 1997-1998 study [6]
demonstrating an HIV prevalence of 23% and 3.5% among
females and males aged 15-19 years, respectively, in Kisumu,
Nyanza’s capital. [7] Little was known about HIV epidemiology in
rural areas, where the majority of Nyanza’s population resides.
In 2003, KEMRI, CDC, ITM, and the London School of
Hygiene and Tropical Medicine (LSHTM) initiated the first HIV-
specific study in Asembo to measure the prevalence of HIV and
sexually transmitted infections (STIs), identify factors associated
with HIV infection, provide a baseline to evaluate a new
adolescent prevention intervention, and inform sample size
calculations for a prospective HIV-incidence cohort. We present
HIV and HSV-2 prevalence and associated factors for 13-34 year
old Asembo residents.
Methods
Ethics Statement
Before study initiation, ethical approval was obtained from the
Kenya Medical Research Institute (KEMRI), the U.S. Centers for
Disease Control and Prevention (CDC), the Institue of Tropical
Medicine (ITM), and the London School of Hygiene and Tropical
Medicine (LSHTM) Ethics Review Committees/Institutional
Review Boards.
Sampling
Asembo is a rural, subsistence farming community in Nyanza.
The entire population of approximately 65,000, over 95% of
whom are Luo, participates in an ongoing DSS maintained by
KEMRI/CDC. [5] Asembo is comprised of compounds or
clusters of houses occupied by family members. DSS staff visit
each compound every four months to collect demographic data
and register all births, deaths, and in-, out-, and trans-migrations.
[5]
Based on Kisumu data from Buve´ et al, [7] we chose a study
population age range of 13-34 years. Using the DSS as a sampling
platform, potential study participants were randomly selected
through stratified sampling by sex and age group. First,
compounds were randomly selected from a DSS list of compounds
housing residents aged 13-34 years. Second, one individual per
compound aged 13-34 years was randomly selected for participa-
tion, through randomly assigned numbers, to minimize potentially
non-independent HIV transmission. For analyses, individual
sample weights were calculated to account for differences in
sampling fractions by the 8 sex- and age-strata (females: 13-15, 16-
19, 20-29, and 30-34 years; males: 13-18, 19-24, 25-29, and 30-34
years) which included adjustments for nonresponse. These weights
were used for all analyses labeled as being weighted. For sample
size and power calculations, we assumed similar HIV prevalence
rates to those in Kisumu. [7] Allowing for acceptable precision
estimates in the sex- and age-strata with the highest anticipated
HIV prevalence plus a migration/refusal rate of 25%, 3960
individuals were randomly selected and approached for study
participation.
Consent Procedures for Adults and Minors
Written informed consent was obtained from all adults and
mature minors before study participation. Minors (,18 years of
age) were classified as ‘‘mature’’ or ‘‘non-mature’’ using legal
definitions. Mature minors were married, pregnant, or a parent
and could consent to study participation, as they can for HIV
voluntary counseling and testing in Kenya. [8] Non-mature
minors required a two-step written consent-assent process. A
parent/guardian was asked for written informed consent for their
minor to participate in the study. After parental/guardian consent
was given, private discussion and thorough explanation of the
study to the minor followed, and the minor was asked to provide
written informed assent to study participation.
Data/Specimen Collection Procedures and Provision of
Test Results
Data were collected from October 2003 through April 2004.
Trained interviewers visited compounds to obtain informed
consent from potential study participants. Participants were invited
to a nearby site on a specified day for the interview and specimen
collection. Study clinicians conducted physical examinations to
diagnose acute illnesses or symptomatic STIs and confirm male
circumcision.
All participants underwent pre-test HIV counseling by certified
counselors before venipuncture. Participants could obtain their
HIV results and post-test counseling confidentially through study
counselors at community health facilities. Adult participants were
encouraged to share their HIV results with sexual partners and
minors with their parent/guardian.
Provision of Services
Participants received free clinical care for common, acute ailments
including STIs and were referred for free tuberculosis diagnosis and
treatment. Sexual partners of participants with STIs were offered free
STI treatment. HIV care and support services were provided through
existing infrastructure developed collaboratively between theMinistry
of Health and CDC’s Global AIDS Program.
Laboratory Procedures
Initially, the HIV testing algorithm used Determine (Abbott
Laboratories, Tokyo, Japan) and Unigold (Trinity Biotech Plc.
Bray, Ireland) rapid tests in parallel. Discordant results were
resolved with Capillus (Trinity Biotech Plc. Bray, Ireland).
Concordant negatives were tested with the sensitive Murex
enzyme immunoassay (Abbot, Dartford, UK). Negative Murex
results were considered negative for HIV-infection. All Murex
HIV-positive samples were further run on Western blot (Genelab
Diagnostics, Belgium) and read according to CDC criteria. [9]
For efficiency and cost, halfway through the study we changed
to parallel testing by ELISA using Vironostika HIV Uniform II
plus O kit (Organon Teknika, Boxtel, the Netherlands) and
Enzygnost (Dade Behring, Marburg, GmbH, Germany). Concor-
dant results were final. Discordant results were run on Western
blot (Genelab Diagnostics, Belgium). No statistical adjustments
were made with this change in the HIV testing algorithm because
a number of systematically selected specimens that had been tested
with the original HIV testing algorithm were retested with the
second algorithm with consistent results.
HSV-2 was screened using an HSV-2 type-specific IgG ELISA
(Kalon Biological, Ltd., Surrey, UK) with a reported sensitivity of
92.3% and specificity of 97.7% in African populations. [10]
Urine pregnancy tests were conducted on-site for all consenting
females not visibly pregnant using Randox, Inc. latex monoclonal
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agglutination test (Antrim, Northern Ireland, UK) and First Sign
HCG One Step (UNIMED International, Inc., South San
Francisco, CA, USA).
Data management and Analyses
Data were collected on optical character recognition enabled
forms that were completed in the field through face-to-face
interviews, transported to the research station, scanned into a
database using Teleform version 8 (Verity, Inc., 2003, Sunnyvale,
California, USA), and exported into Access 2000. Questionnaires
contained embedded internal consistency and validity checks.
Data cleaning and statistical analyses using survey procedures were
performed in SAS versions 8.2 through 9.13 (2003-2005, SAS
Institute, Inc., Cary, North Carolina, USA) and STATA 8.2
(StataCorp LP, 2003, College Station, Texas, USA).
HIV prevalence and univariate aggregate data were weighted to
the population from which the study sample was drawn. Standard
errors were computed that accounted for the sampling design and
the individual’s sampling probability from the sampling strata.
Analyses that are descriptive of the sample attributes are not
weighted. Analyses that are descriptive of the population are
weighted and are labeled as such. All logistic regression models
used weights to account for the probability of selection by age and
sex strata. Separate analyses were conducted for females and
males. Due to gender differences in age of life events (e.g.
marriage), females were age-group adjusted by 13-19 and 20-34
years and males by 13-24 and 25-34 years. Because of the strong
association between HIV infection and marriage, bivariate and
multivariate analyses were conducted separately for sexually active
participants and those who had ever been married. Mutlivariate
analyses were conducted with SAS’s Proc SurveyLogistic.
Marriage was defined as a legal, religious, or customary
agreement or a man and woman living together as married.
Having ever been married included those who were currently
married, separated, divorced, or a widow/widower. Anyone who
had ever had sexual intercourse was considered sexually active.
Polygamy, widow inheritance, and cultural rituals involving sex
are part of Luo culture. [11-14] Ritual sex was defined as engaging
in sexual intercourse to abide by cultural practices and beliefs.
We evaluated factors associated with HIV infection through
logistic regression modeling using software that incorporated the
sampling weights. Using the forward stepwise selection method,
four hierarchical models were constructed: ever sexually active
females and males and ever-married females and males. Each
model included all covariates with a p-value #0.2 on bivariate
analysis. First, sociodemographic variables were entered into the
model beginning with the most significant covariate on bivariate
analysis. Upon finalization of the sociodemographic tier, the same
approach was used to add sexual behavior, other HIV risk factors,
and finally STI-related covariates. Once a covariate was significant
(p-value #0.05) within its tier, it was retained in the final model.
Because STI-related covariates affected most models, we present
the four models with and without STI covariates. The likelihood
ratio test was used to compare statistical models. Although not
significant on bivariate analyses, male circumcision was included
in all male models because of the protection conferred against
HIV. [15-17] Because of co-linearity between marriage and age
group, ‘‘having ever been married’’ was not a covariate in the
‘‘ever sexually active’’ models for females and males.
Results
Of 3960 randomly selected individuals, 2606 (66%) were
eligible for enrollment; almost all others, 1261/1354 (93%), were
ineligible because they had left Asembo. Of the eligible 2606, 1822
(70%) enrolled, 447 (17%) refused, and 337 (13%) consented at
home but did not come to the study site. Enrollment rates were
similar for males and females (70%) but higher among those aged
,20 years (75%) than those aged $20 years (63%, p,0.0001).
Primary reasons for refusal included not wanting blood taken
(37%), partner/parental objection (19%), and not wanting to be
tested for or learn one’s HIV status (18%).
Among 13-19 year olds in the sample, 43.9% of females and
50.2% of males reported they had ever had sexual intercourse.
The median age of sexual debut was 16.5 years for females and
15.5 years for males. The median age of first pregnancy was 18
years. The median age of first marriage was 18 years for females
and 23 years for males.
Among currently married participants in the sample, 72/328
(22.0%) of females and 8/189 (4.2%) of males, were in polygamous
marriages. Additionally, 63.9% (39/61) of widows had been
inherited, and 2.8% (6/214) of ever-married men had inherited a
widow. Of sexually active participants, 102/1202 (8.4%) had
participated in ritual sex. Only 13.2% (77/583) of sexually active
males were circumcised. There was high mobility with only 18%
of female and 48% of male sexually active participants having
lived their entire lives in Asembo.
The median number of lifetime sexual partners for sexually
active participants in our sample was 3 for females and 4 for males.
Over half of sexually active females, 327/619 (52.8%), had sex in
exchange for gifts; 45/619 (7.3%) reported having ever been
forced to have sex. Condom use during the last sexual intercourse
was equally low between never-married males and females (25%).
Among ever-married participants, condom use during the last
sexual intercourse with spousal or non-spousal partners was rare in
females (3.3%) and males (6.9%). Of currently married individuals,
3.7% (12/328) of females and 23.8% (45/189) of males reported
having had sex with a non-spousal partner in the previous six
months.
The population, HIV prevalence for the study area, based on
1762 participants who provided blood specimens and complete
data, weighted by age group and sex was 15.4% overall, 20.5%
among females, and 10.2% among males. Table 1 presents HIV
prevalence of all study participants by demographic characteris-
tics. Females became infected several years younger than males,
and HIV prevalence was higher among females than males until
the fourth decade. (Figure 1) Weighted HSV-2 prevalence was
40.0% overall, 53.0% among females, 25.8% among males, and
remained higher in females for all age groups. (Figure 2) Although
the study was not powered for single year of age-specific estimates,
HIV prevalence in adolescent females increased from 3.1% [95%
Confidence Intervals (CI), 0.0, 6.3] at 16 years to 12.8% (95% CI,
5.7, 19.9) at age 17.
Of 309 females who denied ever having had sexual intercourse
in our sample, 4 (1.3%) were HIV-positive and 5 (1.6%) were
pregnant; 2/249 (0.8%) males who denied having had sexual
intercourse were HIV-positive.
After adjustment for age group and stratification by sex, several
demographic and risk variables were associated with HIV
prevalence among sexually active participants (Table 2). Among
sexually active females, HIV infection was significantly associated
with the following factors: cash income through regular/intermit-
tent employment, being married or widowed, higher number of
lifetime sexual partners, ritual sex, having received an injection in
the previous six months, scarification, HSV-2 infection, and past
treatment for an STI. In multivariate analysis, HIV infection
remained significantly associated with the following factors: older
age, cash income, higher number of lifetime sexual partners, having
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received an injection in the prior six months, and scarification.
Adding STI-related covariates to the model attenuated the positive
association of HIV infection with age and lifetime number of sexual
partners and rendered non-significant the positive association
between HIV infection and scarification or prior STI treatment.
HSV-2 infection remained strongly associated with HIV infection.
Among sexually active males (Table 2), factors significantly
associated with HIV infection included the following: being
married or a widower, higher number of lifetime sexual partners,
having received an injection in the previous six months, HSV-2
infection, and previous STI treatment. In multivariate analysis,
older age and higher number of lifetime sexual partners remained
significantly associated with HIV infection. STI-related covariates
in the model attenuated the association of both age and number of
sexual partners with HIV infection, but HSV-2 infection and prior
STI treatment remained associated with HIV infection.
Marital status was an effect modifier necessitating separate
analyses by gender and marital history. Because few never-married
individuals were HIV-infected, we were unable to conduct
adequate multivariate analyses in this group. For ever-married
participants, univariate analyses of factors associated with HIV
infection are presented in Table 3 and multivariate analyses in
Table 1. Demographic characteristics by weighted HIV prevalence and gender, N = 1762.
Females Males
N
HIV positive
(n)
Weighted HIV
prevalence (%) 95% CIa N
HIV positive
(n)
Weighted HIV
prevalence (%) 95% CI
Total 930 162 20.5 [17.8, 23.2] 832 99 10.2 [8.5, 11.9]
Age (years) median = 19 median = 20 median = 18
IQRb = [15,25] IQR = [16,26] IQR = [15,23]
Age group (years)
13-14 201 3 1.5 [0.0, 3.1] 168 1 0.6 [0.0, 1.7]
15-19 347 29 8.6 [5.7, 11.4] 316 2 0.8 [0.0, 1.8]
20-24 101 34 33.7 [24.7, 42.7] 106 11 10.4 [4.7, 16.1]
25-29 115 42 36.5 [27.9, 45.1] 130 39 30.0 [22.5, 37.5]
30-34 166 54 32.5 [25.8, 39.3] 112 46 41.1 [32.4, 49.7]
Education
Some primary school 540 74 19.9 [16.9, 25.5] 409 26 5.9 [3.8, 8.1]
Completed primary school 239 46 22.7 [17.0, 28.5] 237 40 14.1 [10.1, 18.0]
Beyond primary school 151 28 18.9 [12.4, 25.4] 186 33 14.4 [9.9, 18.9]
Occupation
Has cash incomec 218 84 39.9 [33.2, 46.6] 219 55 21.9 [16.7, 27.0]
Employed 381 129 35.2 [30.2, 40.2] 354 90 21.8 [17.9, 25.7]
Unemployed 117 23 21.3 [13.5, 29.1] 51 4 7.5 [0.3, 14.8]
Student 428 9 2.1 [0.8, 3.5] 427 5 1.2 [0.2, 2.2]
Religion
Muslim groups/Other 163 36 28.7 [21.2, 36.2] 154 16 8.0 [4.5, 11.5]
Protestant groups 539 95 19.8 [16.2, 23.3] 457 60 11.7 [9.0, 14.3]
Catholic groups 226 30 15.8 [10.6, 21.0] 221 23 8.6 [5.3, 11.8]
Marital status
Never married 533 22 4.6 [2.8, 6.5] 618 24 3.8 [2.3, 5.3]
Currently married 328 92 29.4 [24.3, 34.6] 189 65 32.4 [26.0, 38.9]
Polygamous marriage 72 24 35.6 [23.9, 47.3] 8 2 24.6 [0.0, 53.0]
Divorced/Separated 6 2 36.2 [0.0, 76.6] 16 5 31.3 [9.7, 53.0]
Widow/Widower 61 45 77.8 [67.7, 88.0] 9 5 49.7 [17.1, 82.2]
Pregnancy
Has ever been pregnant 433 138 33.2 [28.5, 37.8] --- --- --- ---
Currently pregnant 124 30 26.8 [18.6, 35.0] --- --- --- ---
Sexual activity
Has had sexual intercourse 619 157 27.7 [24.1, 31.4] 583 97 14.1 [11.6, 16.5]
Has never had sexual
intercourse
309 4 1.4 [0.1, 2.7] 249 2 0.8 [0.0, 1.8]
a95% CI, 95% confidence intervals.
bIQR, interquartile range.
cRegular or intermittent employment that provided cash income such as salaried workers, small business owners, casual laborers, etc.
doi:10.1371/journal.pone.0006470.t001
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Figure 1. HIV prevalence by sex and age-group, N=1762.
doi:10.1371/journal.pone.0006470.g001
Figure 2. HSV-2 prevalence by sex and age group, N=1762.
doi:10.1371/journal.pone.0006470.g002
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Table 2. Age-group adjusted risk factors associated with HIV infection by gender among sexually active participants, N = 1202.
Females Males
N Weighted HIV
prevalence (%)
Age
group
aORa
95% CIb P-value N Weighted HIV
prevalence (%)
Age
group
aOR
95% CI P-value
Total 619 27.7 4.2 [2.7, 6.6] ,0.001 583 14.1 11.8 [6.4, 21.6] ,0.001
Age (years), overall median= 21 median= 22 median= 20
IQRc = [18,28] IQR= [18,28] IQR= [17,26]
Demographic characteristics
Education
Some primary school 316 30.1 refd – NSe 230 9.5 ref – NS
Completed primary school 186 27.6 0.8 [0.5, 1.0] 190 17.6 1.1 [0.6, 2.0]
Beyond primary school 117 22.2 0.6 [0.5, 1.2] 163 16.4 1.1 [0.7, 2.4]
Occupation
Has cash incomef 213 40.7 2.1 [1.4, 3.1] ,0.001 215 22.3 1.2 [0.7, 2.0] NS
Religion
Muslim groups/other 117 36.2 ref – NS 109 11.2 ref – NS
Protestant groups 374 25.9 0.8 [0.4, 1.4] 321 16.4 1.6 [0.9, 3.0]
Catholic groups 128 25.2 0.8 [0.5, 1.2] 153 11.1 1.0 [0.5, 2.1]
Marital status
Never married 224 8.6 ref ,0.001 369 5.6 ref – ,0.05
Currently married 328 29.4 3.4 [1.5, 7.7] 189 32.4 2.4 [1.1,5.3]
Divorced/Separated 6 36.2 5.0 [0.8, 21.0] 16 31.3 1.7 [0.5, 5.9]
Widow/Widower 61 77.8 28.5 [10.6, 76.5] 9 49.7 5.2 [1.4, 19.7]
Mobility
Never lived outside Asembo 111 11.4 0.6 [0.3, 1.2] NS 278 12.8 1.0 [0.6, 1.6] NS
Spent.1 night away from home in previous
6 months
197 34.0 1.4 [1.0, 2.1] NS 262 17.0 1.3 [0.7, 2.1] NS
Sexual behavior characteristics
Number of lifetime sexual partners for:
Females: 1 Males: 1-3 144 9.2 ref ,0.001 238 3.1 ref ,0.001
2-4 4-9 394 28.0 2.3 [1.2, 4.8] 210 15.5 2.6 [1.2, 5.7]
$5 $10 80 52.0 6.2 [2.7, 13.9] 129 33.4 5.4 [2.4, 12.1]
Used a condom at last sexual intercourse 68 11.6 0.5 [0.2, 1.1] NS 111 11.6 1.3 [0.7, 2.6] NS
First partner .5 years older 152 32.0 1.1 [0.7, 1.7] NS --- --- --- ---
Ever had sex in exchange for gifts 327 26.6 0.9 [0.6, 1.3] NS --- --- --- ---
Sexual debut outside Asembo 57 25.6 0.8 [0.4, 1.6] NS 78 23.3 1.7 [0.9, 3.2] NS
Ritual sexg 24 49.6 3.8 [2.0, 7.5] ,0.01 78 20.2 1.9 [0.9, 4.0] NS
Has ever been pregnant 433 33.2 1.8 [0.9, 3.6] NS --- --- --- ---
Currently pregnant 120 27.5 0.9 [0.5, 1.5] NS --- --- --- ---
Other risk characteristics
Received injection in previous 6 months 249 35.7 1.8 [1.2, 2.6] ,0.01 209 16.9 1.8 [1.1, 2.9] ,0.05
Ever had scarification 220 34.8 1.7 [1.1, 2.5] 0.01 213 17.9 1.3 [0.8, 2.2] NS
Alcohol intake during previous month 38 34.3 1.4 [0.6, 3.0] NS 170 24.0 1.6 [0.9, 2.6] NS
Circumcised --- --- --- --- 77 14.4 0.8 [0.4, 1.6] NS
Sexually transmitted infections (STI)
Herpes Simplex Virus-2 (HSV-2) infection 405 36.9 5.3 [2.7, 10.7] ,0.001 210 34.6 6.4 [3.2, 11.6] ,0.001
Previous treatment for an STI 41 46.2 2.1 [1.0, 4.2] ,0.05 130 43.8 5.4 [3.0, 9.9] ,0.001
aaOR, age-group adjusted odds ratio. Females by 13-19 and 20-34 years; males by 13-24 and 25-34 years.
b95% CI, 95% confidence intervals.
cIQR, interquartile range.
dref, referrent group.
eNS, not significant.
fRegular or intermittent employment that provided cash income such as salaried workers, small business owners, casual laborers, etc.
gFor never married, this includes ritual sex with anyone; for ever married, this includes ritual sex with non-spousal partner only.
doi:10.1371/journal.pone.0006470.t002
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Table 4. In multivariate analyses of ever-married females,
widowhood, cash income, having received an injection in the
prior six months, and HSV-2 infection were significantly
associated with HIV infection. For ever-married males, a higher
number of lifetime sexual partners and HSV-2 infection was
significantly associated with HIV infection.
Limited data were available on circumstances around injections.
Of 458 sexually active individuals who reported receiving an
injection in the previous six months in our sample, 87% received it
from clinicians, 9% from community health workers, and 4% from
traditional healers/herbalists. Those aged 30-34 years comprised
the highest proportion receiving an injection (42.1%); 15-19 year
olds were the lowest (35.2%).
Discussion
This population-based study in rural Nyanza Province, Kenya,
found a high prevalence of HIV infection among those aged 13-34
years. Despite a decreasing trend in Kenya’s national HIV
prevalence, [18] similarly high rates were reported in the 2003
KDHS for Nyanza Province [3] and the Kenya AIDS Indicator
Survey 2007. [2] In our study, HIV prevalence among females
aged 15-19 years was 12 times higher than their male
counterparts. This substantial gender disparity is found in Kenya
nationwide [3,19] and other African countries. [6,18,20] Social
[21-24] and biological factors may explain this difference. [25]
Young women may have sex with older, more sexually
experienced men, who are more likely to be HIV-infected. [26]
Young women in our study, however, described most of their
sexual experiences to be with peers. Having a first sexual partner
much older in age was not significantly associated with HIV
infection. [27] Biological factors including immature genital tracts,
cervical ectopy, [28] and more efficient male-to-female HIV
transmission [29] likely contribute to the vulnerability of young
women to HIV infection.
HSV-2 may also play a role. The strong association we found
between HIV and HSV-2 infection confirms findings from other
studies. [7,30-37] A meta-analysis of longitudinal studies with
established temporal relationships between HIV and HSV-2
acquisition found that HSV-2 infection increases the risk for
HIV acquisition three-fold. [31] HSV-2 infection could be a
driving force for HIV transmission in our study population.
Including HSV-2 infection in the multivariate model attenuated
the positive association between HIV and a higher lifetime
number of sexual partners. Although under-reporting of lifetime
number of sexual partners is a possible explanation, HSV-2
infection, particularly in young people, may be a more accurate
marker of sexual activity than reported sexual behavior. [7]
Because HSV-2 infection is such a strong co-factor in sexual
transmission of HIV, differences in lifetime number of sexual
partners, depending on HIV prevalence among such partners,
may translate into relatively small differences in risk for HIV
infection in the presence of HSV-2 infection.
Marriage has been associated with risk for HIV infection in sub-
Saharan Africa. [3,7] In our study, widowhood was strongly
associated with HIV infection, presumably because many widows
lost their husbands to AIDS. Being currently married was
significantly associated with HIV infection. HIV prevention efforts
must target married couples. The 2003 KDHS found 17.1% of
couples in Nyanza Province to be HIV discordant and 9.8%
concordantly HIV-infected. [3] The low frequency of condom use
within marriage and the high frequency of extramarital sex among
men in our study suggest that a substantial proportion of married
people in this community will be exposed to HIV infection
through unprotected sexual intercourse with their HIV-infected
spouse.
The potential contribution of unsafe injections to HIV
transmission has been raised [38-42], disputed [43-45], and
continues to be examined. [46] In our study, having received an
injection in the prior six months was associated with HIV infection
for sexually active or ever-married females but not for males or
never-married participants. Additionally, for all participants there
was no association between having received an injection in the
prior six months and having ever had STI treatment. Given this
study’s cross-sectional design, this finding may represent reverse
causality or confounding for which we could not control. Further
investigation through a prospective incidence cohort is warranted.
HIV infection in Africa has been associated with urban-to-rural
and intra-rural human mobility. [47-49] Females in our study
reported more mobility than males; HIV prevalence was lower
among females and males who had lived their entire lives in
Asembo than those who had spent more than one night away from
home in the previous six months. Mobility may be a risk factor for
HIV infection. The 2002 DSS data for Asembo showed substantial
migration. In-migration exceeded out-migration, adults younger
than 30 years were the most migratory, and women migrate more
than men. [5] Although primary reasons for migration included
marriage and seeking employment, health-related reasons cannot
be ruled out. [5] Further investigation is warranted to better
elucidate the roles of mobility and migration in Asembo’s HIV
epidemic.
Recent randomized clinical trials of male circumcision resulted
in an approximate reduction of HIV acquisition by half. [15-17]
Luo males are not routinely circumcised, [3,50] which could
explain the higher HIV prevalence in Asembo compared to non-
Luo areas of Nyanza Province and Kenya. [3,51]
Ritual sex around funerals, polygamy, and widow inheritance
are traditional Luo practices that can facilitate HIV transmission.
[11-14] The low rates of reported ritual sex participation in this
study may reflect a decreasing prevalence of such practices or
underestimate their relevance, due to the young study population.
Traditionally, widow inheritance requires a widow to become the
wife of her late husband’s brother, assuring her and her children
economic and social stability. [11-14] Although we lacked
sufficient power to detect associations between HIV infection
and polygamy, widow inheritance, or ritual sex, the strong
association between HIV infection and widowhood and the high
prevalence of inheritance among widows in our study suggest that
widow inheritance could play a role in this epidemic. [11-14]
Other data regarding HIV prevalence in Nyanza Province
include a second cross-sectional study with different sampling
methodology and age distribution was conducted from 2004-2005
in the neighboring community of Gem. This study of volunteers
aged 15-34 years showed a weighted HIV prevalence of 28.2%
among females and 14.8% among males. [52] Cohen et al. present
HIV prevalence data from a 2006 general population survey in
Kisumu city, the capital of Nyanza Province, conducted to
evaluate antiretroviral therapy-related attitudes and beliefs.
Although an urban setting, they found a similar over HIV
prevalence of 25% in women and 16% in men aged 15-49 years.
[53]
Study limitations exist. Risk factor data in cross-sectional studies
are associations and cannot identify causality. There is potential
for selection bias from migration, because 30% of selected
individuals had moved out of Asembo between the DSS survey
round and study enrollment (,8 months). Ill individuals may have
left the area seeking health care or returned home to die. Healthy
individuals may have left seeking employment or returned to care
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Table3.Age-group adjusted risk factors associatedwithHIV infectionbygender amongparticipantswhohave ever beenmarrieda, N=609.
Females Males
N
Weighted
HIV
prevalence
(%)
Age
group
aORb 95% CIc P-value N
Weighted
HIV
prevalence
(%)
Age
group
aOR 95% CI P-value
Total 395 36.4 1.3 [0.7, 2.7] NSd 214 33.1 3.2 [1.0, 9.7] ,0.05
Age (years), overall median = 27 median = 26 median = 28
IQRe = [23,30] IQR = [22,30] IQR = [25,31]
Demographic characteristics
Education
Some primary school 196 40.3 reff – NS 60 34.6 ref – NS
Completed primary school 127 33.4 0.7 [0.5, 1.1] 95 29.2 0.7 [0.4, 1.4]
Beyond primary school 72 31.6 0.8 [0.5, 1.4] 59 37.6 1.0 [0.5, 2.0]
Occupation
Has cash incomeg 189 41.8 1.6 [1.0, 2.5] ,0.05 135 36.9 0.8 [0.4, 1.4] NS
Religion
Muslim groups/Other 87 43.4 ref – NS 51 20.7 ref – NS
Protestant groups 236 34.4 0.8 [0.5, 1.4] 114 39.1 2.3 [1.1, 4.6]
Catholic groups 72 34.1 0.8 [0.4, 1.5] 49 31.6 1.7 [0.7, 4.0]
Marital status
Currently married 328 29.4 ref – p,0.001 189 32.4 ref NS
Polygamous marriage 72 35.6 1.5 [0.8, 2.7] – 8 24.6 0.5 [0.1, 2.6]
Divorced/Separated 6 36.2 1.4 [0.2, 8.4] 16 31.3 0.8 [0.3, 2.2]
Widow/Widower 61 77.8 8.4 [4.4, 16.0] 9 49.7 2.1 [0.6, 7.1]
Mobility
Never lived outside Asembo 10 33.3 1.0 [0.2, 4.1] NS 109 30.0 0.8 [0.5, 1.5] NS
Spent.1 night away from home in previous 6 months 146 41.3 1.4 [0.9, 2.2] NS 121 33.9 1.1 [0.6, 1.9] NS
Sexual behavior characteristics
Number of lifetime sexual partners for:
Females: 1 Males: 1-3 26 21.8 ref 0.001 30 21.4 ref ,0.01
2-4 4-9 299 32.9 1.8 [0.7, 4.7] 96 24.5 1.0 [0.4, 2.4]
.5 .10 69 55.2 4.4 [1.5, 12.9] 85 46.3 2.6 [1.1, 6.0]
Age difference with first partner .5 years 131 34.8 0.9 [0.6, 1.4] NS 18 16.1 0.4 [0.1, 1.2] NS
If currently married, had extramarital sex in previous 6
months
12 32.9 1.2 [0.3, 4.3] NS 44 33.3 1.1 [0.5, 2.4] NS
Had ritual sex with non-spousal partner 11 94.2 29.6 [4.1, 213.6] ,0.05 24 38.2 1.2 [0.5, 3.2] NS
Has ever been pregnant 386 36.0 0.7 [0.1, 3.2] NS --- --- --- ---
Currently pregnant 91 30.9 0.7 [0.4, 1.3] NS --- --- --- ---
Other risk characteristics
Received injection in previous 6 months 180 44.4 1.9 [1.2, 2.9] ,0.01 76 43.6 2.2 [1.2, 3.9] ,0.01
Ever had scarification 157 42.6 1.5 [1.0, 2.4] NS 93 32.8 1.1 [0.6, 1.9] NS
Alcohol intake during previous month 23 45.8 1.5 [0.6, 3.7] NS 91 33.0 1.0 [0.5, 1.7] NS
Circumcised --- --- --- --- --- 35 23.6 0.5 [0.2, 1.1] NS
Sexually transmitted infections (STI)
Herpes Simplex Virus-2 (HSV-2) infection 341 39.8 3.5 [1.6, 7.7] 0.001 139 44.0 3.8 [1.9, 7.7] ,0.001
Previous treatment for an STI 31 48.3 1.7 [0.8, 3.7] NS 96 45.5 2.5 [1.4, 4.4] ,0.01
aIncludes currently married, separated, divorced, or widowed.
baOR, age-group adjusted odds ratio. Females by 13-19 and 20-34 years; Males by 13-24 and 25-34 years.
c95% CI, 95% confidence intervals.
dNS, not significant.
eIQR, interquartile range.
fref, referrent group.
gRegular or intermittent employment that provided cash income such as salaried workers, small business owners, casual laborers, etc.
doi:10.1371/journal.pone.0006470.t003
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for ill relatives. By requiring participants to visit a nearby site, we
may have selected for healthier individuals. Since study partici-
pation took up to four hours, we may have selected for individuals
who were wealthier, unemployed, or had time. As the first HIV-
specific research conducted in Asembo, individuals with self-
perceived low HIV risk may have self-selected to participate. Most
of these potential biases would have resulted in lower HIV
prevalence estimates. However, if the individuals aged $20 years
who refused study participation did so because they engaged in
risky sexual behavior and did not want to know their HIV status,
their non-participation might have resulted in an underestimation
of HIV prevalence.
Recall bias due to illness, gender, or age can occur when
describing sexual histories or risk behaviors. Sexual behavior
interviews are limited by the accuracy of self-reporting, and
women, particularly adolescent females, frequently underreport
sexual experiences. [25]
Conclusion
Our study shows a large HIV-burden in this area of rural
Nyanza. High HIV transmission rates are probable given the rapid
increase in age-specific HIV prevalence among adolescent
females. Without massive and drastic prevention and treatment
efforts, AIDS will continue to devastate Asembo. Community-
wide delivery of HIV counseling and testing with HIV/AIDS
treatment provision merits exploration. Alterations in cultural
perceptions and practices are needed to delay sexual debut, reduce
the number of sexual partners, promote mutual faithfulness to
known seronegative partners, implement 100% condom use with
casual partners, and discourage inter-generational and transac-
tional sex. Community elders and opinion leaders are urged to
encourage non-sexual substitutions for ritual sex and empower
widows refusing to be inherited. In an area with such high HIV
prevalence, key life decisions should be made based on known
HIV serostatus.
Qualitative data are required to better elucidate circumstances
around individual HIV transmission/acquisition events and identify
behaviors driving the epidemic in this area. Interventions to achieve
high male circumcision rates are needed along with continued
research on additional HIV prevention strategies including HIV
vaccines, microbicides, pre-exposure chemoprophylaxis, and vac-
cine and chemotherapeutic agents against HSV-2.
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